Sharing information doesn’t always come naturally in outsourcing relationships. This may be rooted in the early days of outsourcing, when there were more concerns about compromising one’s IP in the subcontracting process. However, as the dynamics of outsourcing relationships evolve, many drug innovators are shifting away from a client-vendor perspective (where the customer is always right) and are more than willing to improve sponsor-CMO relationships.
Outsourcing motivations are important considerations to identify the best outsourcing approach and should influence the type of relationships your organization develops with CMOs. Whether it’s cost-efficiency or time-savings, access to technologies, skills, scientific expertise, or capacity, there are many reasons for hiring a CMO.
When it comes to choosing a contract manufacturer, reducing the amount of time it takes to select and qualify a supplier may save weeks or months as opposed to hours. Time reduction combined with the comfort of familiarity has paved the way for the preferred provider outsourcing model’s popularity.
The long history and market dominance of oral dosage forms have made this category of drug product a good candidate for outsourced manufacturing. So how will the outsourced oral-dose manufacturing market look in five years?